PRP reduces pain in knee osteoarthritis, but has no effect on physical function .
This study has been identified as potentially high impact.
OE's AI-driven High Impact metric estimates the influence a paper is likely to have by integrating signals from both the journal in which it is published and the scientific content of the article itself.
Developed using state-of-the-art natural language processing, the OE High Impact model more accurately predicts a study's future citation performance than journal impact factor alone.
This enables earlier recognition of clinically meaningful research and helps readers focus on articles most likely to shape future practice.
A randomized clinical trial evaluating plasma rich in growth factors (PRGF-Endoret) versus hyaluronic acid in the short-term treatment of symptomatic knee osteoarthritis
Arthroscopy. 2012 Aug;28(8):1070-8. doi: 10.1016/j.arthro.2012.05.011176 patients were randomized to determine the efficacy of three intra-articular injections of plasma rich in growth factors (PRGF) versus hyaluronic acid (HA) injections in the treatment of symptomatic knee osteoarthritis. Clinical outcome using the Western Ontario McMaster Universities Osteoarthritis Index (WOMAC) was measured over 6 months. The results indicated that a greater percentage of patients treated with the platelet-rich plasma (PRP) product experienced at least a 50% reduction in pain, however mean WOMAC pain, stiffness and function subscale scores did not significantly differ between treatments.
Unlock the Full ACE Report
You have access to 4 more FREE articles this month.
Click below to unlock and view this ACE Reports
Unlock Now
Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics